Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Identifying Novel Modifiers of Embryonic Globin Expression By Combining Chipseq, Rnaseq and eQTL Mapping in the Adult Nan Mouse Model

Danitza Nebor, PhD, Kevin R. Gillinder, PhD, Raymond F. Robledo, PhD, Joel H. Graber, PhD, Vivek Philip, PhD, Melissa Ilsley, BSc, James J. Bieker, PhD, Andrew Perkins, PhD, Luanne L. Peters, PhD

Blood (2016) 128 (22): 398.

https://doi.org/10.1182/blood.V128.22.398.398

Published: 2016

Journal Articles

the Charlson Comorbidity Index Predicts Survival Following Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia Patients

Osamu Imataki, Shumpei Uchida, Maki Oku, Shigeyuki Yokokura, Makiko Uemura, Norimitsu Kadowaki, MD PhD

Blood (2015) 126 (23): 5146.

https://doi.org/10.1182/blood.V126.23.5146.5146

Published: 2015

Journal Articles

Genomic-Wide Analysis By High Resolution SNP Array Identifies Novel Genomic Alteration in Acute Myeloid Leukemia

Blood (2015) 126 (23): 2600.

https://doi.org/10.1182/blood.V126.23.2600.2600

Published: 2015

Journal Articles

Regions on Chromosomes 1 and 14 Are Associated with VWF:Ag Levels in African Americans Using Mapping By Admixture Linkage Disequilibrium

Andrew D Paterson, MD, Nicole M Roslin, Pamela A. Christopherson, Daniel B Bellissimo, PhD, Veronica H Flood, MD, Sandra L. Haberichter, PhD, Robert R Montgomery, MD, Zimmerman Program Investigators

Blood (2014) 124 (21): 2840.

https://doi.org/10.1182/blood.V124.21.2840.2840

Published: 2014

Journal Articles

BCL -2 Family Of Genes Is a Key Regulator In The Pathogenesis Of SF3B1 Mutant and Wild Type MDS With Ring Sideroblasts and Represents a Novel Drug Target In This Disease

Valeria Visconte, PhD, Reda Z Mahfouz, MD/PhD, Ali Tabarroki, MD, Edy Hasrouni, Heesun J. Rogers, MD, PhD, Yogen Saunthararajah, MD, Brian T. Hill, MD, PhD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD, MS, John Barnard, Ramon V. Tiu, MD

Blood (2013) 122 (21): 263.

https://doi.org/10.1182/blood.V122.21.263.263

Published: 2013

Journal Articles

BCR-ABL IS Expression at Diagnosis and After 3 or 6 Months of Treatment Predicts CML Response to IMATINIB Therapy.

Paolo Vigneri, MD, PhD, Fabio Stagno, MD, Stefania Stella, PhD, Alessandra Cupri, MD, PhD, Michele Massimino, PhD, Agostino Antolino, MD, Vincenzo Abbadessa, MD, Maura Brugiatelli, MD, Patrizia Guglielmo, MD, Caterina Musolino, MD, Diamante Turri, MD, Mario Russo, MD, Guido Pagnucco, MD, Michele Rizzo, MD, Maurizio Musso, MD, Fortunato Morabito, MD, Luciano Levato, Angelo Messina, MD, Francesco Di Raimondo, MD

Blood (2010) 116 (21): 3426.

https://doi.org/10.1182/blood.V116.21.3426.3426

Published: 2010

Journal Articles

Melphalan and Dexamethasone Plus Bortezomib Induces Hematologic and Organ Responses in AL-Amyloidosis with Tolerable Neurotoxicity.

Jeffrey A Zonder, MD, Vaishali Sanchorawala, MD, Rachel M. Snyder, PhD, Jeffrey Matous, MD, Howard Terebelo, MD, Nalini Janakiraman, MD, Markus Y Mapara, MD, PhD, Silvana Lalo, MBA, Nishant Tageja, MD, Craig Webb, PhD, David Monsma, PhD, Catherine Sellers, RN, Judith Abrams, Statistician, Cristina Gasparetto, MD

Blood (2009) 114 (22): 746.

https://doi.org/10.1182/blood.V114.22.746.746

Published: 2009

Journal Articles

Dasatinib Is Associated with Rapid and Durable Complete Hematologic Responses in Patients with Chronic-Phase Chronic Myeloid Leukemia (CPCML).

Delong Liu, MD, PhD, Yousif Matloub, Jaydip Mukhopadhyay, David Liu, Stuart L Goldberg

Blood (2008) 112 (11): 2128.

https://doi.org/10.1182/blood.V112.11.2128.2128

Published: 2008

Journal Articles

Modeling Anemia of Aging in Inbred Mouse Strains

Luanne L. Peters, PhD, Shirng-wern Tsaih, PhD, Rong Yuan, PhD

Blood (2008) 112 (11): 3444.

https://doi.org/10.1182/blood.V112.11.3444.3444

Published: 2008

Journal Articles

Safety and Efficacy of Subcutaneous (SC) Omacetaxine Mepesuccinate in Imatinib(IM)-Resistant Chronic Myeloid Leukemia (CML) Patients (pts) with the T315I Mutation – Results of An Ongoing Multicenter Phase II Study.

Jorge Cortes, MD, H. Jean Khoury, MD, Sélim Corm, MD, Franck E Nicolini, MD, PhD, Jeffrey H. Lipton, MD, PhD, Dan Jones, MD, PhD, Andreas Hochhaus, MD, Adam R Craig, MD, PhD, Annie-Claude Benichou, MD, Eric Humphriss, Hagop Kantarjian

Blood (2008) 112 (11): 3239.

https://doi.org/10.1182/blood.V112.11.3239.3239

Published: 2008

Journal Articles

SNP-a Karyotyping Provides a Clonal Molecular Marker and Is Associated with a High Incidence of Segmental Uniparental Disomy in Patients with CMML

Michael McDevitt, MD, PhD, Andrew Jeffrey Dunbar, BS, Christine O’Keefe, Hideki Makishima, MD, PhD, Ramon V. Tiu, MD, BS, Lukasz Gondek, Judith E. Karp, Xiao-Fei Wang, Mark J. Levis, MD, PhD, Jaroslaw Maciejewski

Blood (2008) 112 (11): 3657.

https://doi.org/10.1182/blood.V112.11.3657.3657

Published: 2008

Journal Articles

PHA-739358, an Aurora Kinase Inhibitor, Induces Clinical Responses in Chronic Myeloid Leukemia Harboring T315I Mutations of BCR-ABL.

Ronald L. Paquette, MD, Neil P. Shah, MD, PhD, Charles L. Sawyers, MD, Giovanni Martinelli, MD, Nicoll John, Meenal Chalukya, Maurizio Rocchetti, PhD, Carina Fiocchi, MD, Sylvia Comis, MD, Laura Capolongo, MD, Bernard Laffranchi, MD

Blood (2007) 110 (11): 1030.

https://doi.org/10.1182/blood.V110.11.1030.1030

Published: 2007

Journal Articles

SNP-A Karyotyping Demonstrates a High Incidence of Segmental Uniparental Disomy in Patients with CMML and Shows Impact of Newly Identified Chromosomal Aberrations on Clinical Course.

Andrew J. Dunbar, BS, Lukasz P. Gondek, MD, Ramon V. Tiu, MD, Judith E. Karp, MD, Xiao Fei P. Wang, MD, PhD, Mark J. Levis, MD, Michael A. McDevitt, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2007) 110 (11): 2428.

https://doi.org/10.1182/blood.V110.11.2428.2428

Published: 2007

Journal Articles

Detection of Recurrent Uniparental Disomy and Cryptic Chromosomal Abnormalities in MDS/MPD-U and MDS/MPD-Derived Secondary AML

Lukasz P. Gondek, MD, Andrew J. Dunbar, Michael A. McDevitt, MD, PhD, Hadrian Szpurka, Mikkael A. Sekeres, MD, MS, Jaroslaw P. Maciejewski, MD, PhD

Blood (2007) 110 (11): 1542.

https://doi.org/10.1182/blood.V110.11.1542.1542

Published: 2007

Journal Articles

Efficacy of Dasatinib in Patients with Accelerated-Phase Chronic Myelogenous Leukemia with Resistance or Intolerance to Imatinib: 2-Year Follow-Up Data from START-A (CA180-005).

Francois Guilhot, MD, Jane F. Apperley, MD, Dong-Wook Kim, MD, Gianantonio Rosti, MD, Xiaobin Yuan, Jan M.A. Van Tornout, MD, Felix T. Garzon, MD, Jorge Cortes, MD

Blood (2007) 110 (11): 470.

https://doi.org/10.1182/blood.V110.11.470.470

Published: 2007

Journal Articles

Enhancement of Cytogenetic Diagnosis of Myeloid Disorders through Application of SNP-Array-Based Karyotyping.

Lukasz P. Gondek, MD, Ramon Tiu, MD, Marcin Wlodarski, MD, Christine O’Keefe, PhD, Michael McDevitt, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2007) 110 (11): 108.

https://doi.org/10.1182/blood.V110.11.108.108

Published: 2007

Journal Articles

Hematologic and Cytogenetic Responses in Imatinib-Resistant Accelerated and Blast Phase Chronic Myeloid Leukemia (CML) Patients Treated with the Dual SRC/ABL Kinase Inhibitor BMS-354825: Results from a Phase I Dose Escalation Study.

Moshe Talpaz, Hagop Kantarjian, Neil P. Shah, Nicholas Donato, John Nicoll, Stephen A. Bai, Fei Huang, Edwin Clark, Arthur P. DeCillis, Charles Sawyers

Blood (2004) 104 (11): 20.

https://doi.org/10.1182/blood.V104.11.20.20

Published: 2004

NARROW

Identifying Novel Modifiers of Embryonic Globin Expression By Combining Chipseq, Rnaseq and eQTL Mapping in the Adult Nan Mouse Model

the Charlson Comorbidity Index Predicts Survival Following Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia Patients

Genomic-Wide Analysis By High Resolution SNP Array Identifies Novel Genomic Alteration in Acute Myeloid Leukemia

Regions on Chromosomes 1 and 14 Are Associated with VWF:Ag Levels in African Americans Using Mapping By Admixture Linkage Disequilibrium

BCL -2 Family Of Genes Is a Key Regulator In The Pathogenesis Of SF3B1 Mutant and Wild Type MDS With Ring Sideroblasts and Represents a Novel Drug Target In This Disease

BCR-ABL IS Expression at Diagnosis and After 3 or 6 Months of Treatment Predicts CML Response to IMATINIB Therapy.

Melphalan and Dexamethasone Plus Bortezomib Induces Hematologic and Organ Responses in AL-Amyloidosis with Tolerable Neurotoxicity.

Dasatinib Is Associated with Rapid and Durable Complete Hematologic Responses in Patients with Chronic-Phase Chronic Myeloid Leukemia (CPCML).

Modeling Anemia of Aging in Inbred Mouse Strains

Safety and Efficacy of Subcutaneous (SC) Omacetaxine Mepesuccinate in Imatinib(IM)-Resistant Chronic Myeloid Leukemia (CML) Patients (pts) with the T315I Mutation – Results of An Ongoing Multicenter Phase II Study.

SNP-a Karyotyping Provides a Clonal Molecular Marker and Is Associated with a High Incidence of Segmental Uniparental Disomy in Patients with CMML

PHA-739358, an Aurora Kinase Inhibitor, Induces Clinical Responses in Chronic Myeloid Leukemia Harboring T315I Mutations of BCR-ABL.

SNP-A Karyotyping Demonstrates a High Incidence of Segmental Uniparental Disomy in Patients with CMML and Shows Impact of Newly Identified Chromosomal Aberrations on Clinical Course.

Detection of Recurrent Uniparental Disomy and Cryptic Chromosomal Abnormalities in MDS/MPD-U and MDS/MPD-Derived Secondary AML

Efficacy of Dasatinib in Patients with Accelerated-Phase Chronic Myelogenous Leukemia with Resistance or Intolerance to Imatinib: 2-Year Follow-Up Data from START-A (CA180-005).

Enhancement of Cytogenetic Diagnosis of Myeloid Disorders through Application of SNP-Array-Based Karyotyping.

Hematologic and Cytogenetic Responses in Imatinib-Resistant Accelerated and Blast Phase Chronic Myeloid Leukemia (CML) Patients Treated with the Dual SRC/ABL Kinase Inhibitor BMS-354825: Results from a Phase I Dose Escalation Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only